Magellan Health, Click Therapeutics team-up to launch a mobile-enabled smoking cessation program

CLICKOTINE

Scottsdale, Arizona-based Magellan Health has teamed-up with Click Therapeutics to launch a fully digital and integrated smoking cessation program.

The two companies will leverage Magellan’s clinical coaching and pharmacy benefit management (PBM) capabilities with Click’s technology and machine learning platform, including the mobile app called CLICKOTINE, to create this all-in-one solution. The full program that includes access to a real-time data analytics portal will be available to Magellan’s employer, managed care and government customers.

“We believe that smoking cessation programs must be personalized, easy-to-use and include a combination of both live coaching and mobile solutions to help individuals reach their personal goal,” Lynn Hamilton, senior vice president of employer markets with Magellan Health, said in a statement. “This solution leverages Magellan’s expertise in the behavioral health field along with its PBM capabilities, as well as Click’s technology and adaptive data science platform, to help change behavior and allow individuals to live a healthier life.”

The CLICKOTINE smoking cessation platform works in tandem with Magellan’s resources, including access to live coaching, a clinical call center and PBM resources to provide quit aids such as a nicotine replacement therapy. The platform empowers individuals to take control of their own health and behaviors, and equips healthcare providers and payers with tools to more effectively and efficiently manage patient care.

Also as part of the partnership, Magellan Health’s chief medical officer of medical and digital innovation Dr. Seth Feuerstein will join Click Therapeutics’ board of directors.